Key Insights

Highlights

Treatment Research

1 treatments under study, led by Test Gut Microbiota Scfas And Glucolipid Metabolism And Insulin Sensitivity

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04399434Unknown

Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns

Showing all 1 trials

Research Network

Common Treatments

  • Test Gut Microbiota Scfas And Glucolipid Metabolism And Insulin Sensitivity1

Active Sponsors

  • Second Affiliated Hospital of Wenzhou Medical University1

Top Investigators

  • Ying Hua1

    Second Affiliated Hospital of Wenzhou Medical University

Related Conditions

  • Fetal Growth Restriction1
  • Fetal Macrosomia1
  • Gut Microbiota1

Activity Timeline